Abnormal muscle vascular responses during exercise in myocardial infarction patients.

[1] Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286–91. [2] Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009;24:1574–9. [3] Solomon SD, Dobson J, Pocock S, et al. For the Candesartan in Heart failure— Assessment of Reduction in Mortality and morbidity (CHARM) investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007;116:1482–7. [4] Kataoka H. A new monitoring method for the estimation of body fluid status by digital weight scale incorporating bioelectrical impedance analyzer in definite heart failure patients. J Card Fail 2009;15:410–8. [5] Kataoka H. Novel monitoring method for management of heart failure: combined measurement of body weight and bioimpedance index of body fat percentage. Future Cardiol 2009;5:541–6. [6] Kataoka H. Detection of preclinical body fluid retention in established heart failure patients during follow-up by a digital weight scale incorporating a bioelectrical impedance analyzer. Congest Heart Fail 2012;18:37–42. [7] Stall SH, Ginsberg NS, DeVita MV, et al. Comparison of five body-composition methods in peritoneal dialysis patients. Am J Clin Nutr 1996;64:125–30. [8] Deurenberg P, Andreoli A, Borg P, et al. The validity of predicted body fat percentage from bodymass index and from impedance in samples of five European populations. Eur J Clin Nutr 2001;55:973–9. [9] Schroeder KL, Sallustio JE, Ross EA. Continuous haematocrit monitoring during intradialytic hypotention: precipitous decline in plasma refill rates. Nephrol Dial Transplant 2004;19:652–6. [10] Booth J, Pinney J,DavenportA.Dochanges in relativebloodvolumemonitoringcorrelate to hemodialysis-associated hypotension? Nephron Clin Pract 2011;117:c179–83. [11] Boyle A, Sobotka PA. Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 2006;12:247–9. [12] Kataoka H. Short-term dynamic changes in hematologic and biochemical tests during follow-up of definite heart failure patients. Int J Cardiol 2010;144:441–4. [13] Packer M, Abraham WT, Mehra MR, et al. For the Prospective Evaluation and Identification of Cardiac Decompensation by ICG Test (PREDICT) Study Investigators and Coordinators. Utility of impedance cardiography for the identification of shortterm risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 2006;47:2245–52. [14] Tang WHW, Tong W. Measuring impedance in congestive heart failure: current options and clinical applications. Am Heart J 2009;157:402–11. [15] Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int 2006;69:1609–20.